John Tucker is the founder of scPharmaceuticals. Latest round: Series B. Backed by OrbiMed, Sun Pharmaceutical Industries, 5AM Ventures.
John Tucker is the CEO of scPharmaceuticals, a biopharmaceutical company focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's lead product is proprietary subcutaneous furosemide, enabled by the patented sc2Wear Infusor. Prior to scPharmaceuticals, Tucker was CEO of Alcresta and senior VP and chief commercial officer at Incline Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library